Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.8 CAD -0.71% Market Closed
Market Cap: 1.1B CAD

Cronos Group Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cronos Group Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Change in Working Capital
-$8.1m
CAGR 3-Years
-69%
CAGR 5-Years
37%
CAGR 10-Years
-55%
Canopy Growth Corp
TSX:WEED
Change in Working Capital
-CA$41.4m
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
-56%
Aurora Cannabis Inc
TSX:ACB
Change in Working Capital
CA$10.2m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Change in Working Capital
CA$9.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Change in Working Capital
-CA$46.7m
CAGR 3-Years
-48%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
S
SugarBud Craft Growers Corp
XTSX:SUGR
Change in Working Capital
-CA$11.8m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.68 CAD
Overvaluation 40%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Change in Working Capital?
Change in Working Capital
-8.1m USD

Based on the financial report for Mar 31, 2025, Cronos Group Inc's Change in Working Capital amounts to -8.1m USD.

What is Cronos Group Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-55%

The average annual Change in Working Capital growth rates for Cronos Group Inc have been -69% over the past three years , 37% over the past five years , and -55% over the past ten years .

Back to Top